BackSamrat Pharmachem Limited Overview

Samrat Pharmachem Limited Total Liabilities

Samrat Pharmachem Limited's total liabilities is $-680M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$-681.79M
↓ 5.04% YoYΔ $36.21M vs prior year quarter

Peer trimmed avg / median

Loading

Samrat Pharmachem Limited Total Liabilities History

Loading

Samrat Pharmachem Limited vs. peers: Total Liabilities Comparison

Loading

Samrat Pharmachem Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Samrat Pharmachem Limited (SAMRATPH.BO) FAQ

As of the most recent data (June 2026), SAMRATPH.BO shows a total liabilities of $-680M. That compares with $-720M in the prior-year period — up 5.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAMRATPH.BO's total liabilities is now $-680M (was $-720M) — a 5.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Samrat Pharmachem Limited is outperforming or lagging.

Tracking SAMRATPH.BO's total liabilities over time shows whether Samrat Pharmachem Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $-680M That compares with $-720M in the prior-year period — up 5.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Samrat Pharmachem Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $-680M) with ownership activity and broader fundamentals.

Questions & Answers